Authored Items
Considerations in Multiple Myeloma: Perspectives on Relevant End Points of Clinical Trials
Sagar Lonial, MD, Shaji Kumar, MD, Gail M. Sulski, RN, MS, FNP, AOCNP, Katherine Sanvidge Shah, PharmD, BCOP
Supplements
Considerations in Multiple Myeloma: Hard-to-Treat Patients
Elizabeth Bilotti, MSN, APRN, BC, OCN®, Kamakshi V. Rao, PharmD, BCOP, Shaji Kumar, MD
Supplements
Last modified: November 22, 2010